132 related articles for article (PubMed ID: 18055713)
1. When is a pathology review indicated in endometrial cancer?
Kwon JS; Francis JA; Qiu F; Weir MM; Ettler HC
Obstet Gynecol; 2007 Dec; 110(6):1224-30. PubMed ID: 18055713
[TBL] [Abstract][Full Text] [Related]
2. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
3. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
4. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
5. Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.
Scholten AN; van Putten WL; Beerman H; Smit VT; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van Lent M; Creutzberg CL;
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):834-8. PubMed ID: 15927414
[TBL] [Abstract][Full Text] [Related]
6. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.
Scholten AN; Smit VT; Beerman H; van Putten WL; Creutzberg CL
Cancer; 2004 Feb; 100(4):764-72. PubMed ID: 14770433
[TBL] [Abstract][Full Text] [Related]
8. Coexisting ovarian malignancy in young women with endometrial cancer.
Walsh C; Holschneider C; Hoang Y; Tieu K; Karlan B; Cass I
Obstet Gynecol; 2005 Oct; 106(4):693-9. PubMed ID: 16199623
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer.
Parthasarathy A; Kapp DS; Cheung MK; Shin JY; Osann K; Chan JK
Obstet Gynecol; 2007 Dec; 110(6):1237-43. PubMed ID: 18055715
[TBL] [Abstract][Full Text] [Related]
10. The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.
Neubauer NL; Havrilesky LJ; Calingaert B; Bulusu A; Bernardini MQ; Fleming ND; Bland AE; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):511-6. PubMed ID: 19144394
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.
Zusterzeel PL; Bekkers RL; Hendriks JC; Neesham DN; Rome RM; Quinn MA
Acta Obstet Gynecol Scand; 2008; 87(2):240-6. PubMed ID: 18231895
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.
Leitao MM; Kehoe S; Barakat RR; Alektiar K; Gattoc LP; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):244-8. PubMed ID: 18752842
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality.
O'Brien DJ; Flannelly G; Mooney EE; Foley M
BJOG; 2009 Jun; 116(7):991-4. PubMed ID: 19522800
[TBL] [Abstract][Full Text] [Related]
14. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
[TBL] [Abstract][Full Text] [Related]
15. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma.
Chang SJ; Kim WY; Yoon JH; Yoo SC; Chang KH; Ryu HS
Acta Obstet Gynecol Scand; 2008; 87(12):1361-9. PubMed ID: 18951214
[TBL] [Abstract][Full Text] [Related]
16. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.
Chong I; Hoskin PJ
Brachytherapy; 2008; 7(2):195-9. PubMed ID: 18358790
[TBL] [Abstract][Full Text] [Related]
17. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
18. The management of inoperable Stage I endometrial cancer using intracavitary brachytherapy alone: a 20-year institutional review.
Shenfield CB; Pearcey RG; Ghosh S; Dundas GS
Brachytherapy; 2009; 8(3):278-83. PubMed ID: 19230787
[TBL] [Abstract][Full Text] [Related]
19. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
Kuoppala T; Mäenpää J; Tomas E; Puistola U; Salmi T; Grenman S; Lehtovirta P; Fors M; Luukkaala T; Sipilä P
Gynecol Oncol; 2008 Aug; 110(2):190-5. PubMed ID: 18534669
[TBL] [Abstract][Full Text] [Related]
20. Positive adnexal or uterine serosal involvement in stage IIIC endometrial cancer is an adverse factor for recurrence.
Hétu V; Petignat P; Wu Y; Drouin P; Sauthier P; Provencher D; Gauthier P
Gynecol Obstet Invest; 2009; 67(3):173-7. PubMed ID: 19088481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]